Earnings History Data for Avadel Pharmaceuticals plc (AVDL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		AVDL	Avadel Pharmaceuticals plc	1,530	-0.03	-0.06	-0.41	Avadel Pharmaceuticals plc GAAP EPS of -$0.03 beats by $0.03, revenue of $50M beats by $1.37M [11/12/2024 9:35 AM]	13.05	-3.25 (-19.91%)	15.51	-0.79 (-4.85%)	10.25 - 19.09	4,623,856	1,390,000	26,645
Avadel Pharmaceuticals plc GAAP EPS of -$0.03 beats by $0.03, revenue of $50M beats by $1.37M [11/12/2024 9:35 AM] Avadel: Q3 Earnings Snapshot [2024-11-12 07:21AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results [2024-11-12 07:00AM] Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings [Nov-11-24 07:10AM]
08-08-2024	PM		AVDL	Avadel Pharmaceuticals plc	1,600	-0.14	-0.17	-0.70		15.69	-0.42 (-2.58%)	17.36	1.26 (7.83%)	9.50 - 19.09	2,171,935	810,000	14,802

08-05-2024	PM		AVDL	Avadel Pharmaceuticals plc	1,690	-0.30	-0.25	-0.48	Avadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28M [5/8/2024 7:49 AM]	16.21	-1.97 (-10.84%)	16.10	-2.08 (-11.44%)	9.50 - 19.09	4,025,661	800,000	19,019
Avadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28M [5/8/2024 7:49 AM] Avadel Pharmaceuticals plc Q1 2024 Earnings Preview [5/7/2024 11:18 AM]
04-03-2024	PM		AVDL	Avadel Pharmaceuticals plc	1,130	-0.32	-0.28	-0.44	Avadel Pharmaceuticals GAAP EPS of -$0.32 misses by $0.07, revenue of $19.5M misses by $6.2M [3/4/2024 6:34 AM]	16.23	2.51 (18.26%)	14.00	0.28 (2.04%)	8.00 - 17.24	9,763,038	1,610,000	49,178
Avadel Pharmaceuticals GAAP EPS of -$0.32 misses by $0.07, revenue of $19.5M misses by $6.2M [3/4/2024 6:34 AM] Avadel surges after jury rules in favor of Jazz, royalty rate lower than requested [3/4/2024 3:03 PM]
08-11-2023	PM		AVDL	Avadel Pharmaceuticals plc	959.81	-0.41	-0.35	-0.33	Avadel Pharmaceuticals GAAP EPS of -$0.41 misses by $0.04, revenue of $7.01M beats by $1.88M [11/8/2023 7:15 AM]	11.63	1.25 (12.04%)	11.50	1.12 (10.79%)	5.64 - 16.85	2,741,003	480,000	23,389
Avadel Pharmaceuticals Q3 2023 Earnings Preview [11/7/2023 12:30 PM] Avadel Pharmaceuticals GAAP EPS of -$0.41 misses by $0.04, revenue of $7.01M beats by $1.88M [11/8/2023 7:15 AM]
09-08-2023	PM		AVDL	Avadel Pharmaceuticals plc	1,030	-0.70	-0.39	-0.50	Avadel Pharmaceuticals GAAP EPS of -$0.83 misses by $0.45, revenue of $1.5M beats by $0.77M [8/9/2023 7:08 AM]	12.84	-0.67 (-4.96%)	13.40	-0.11 (-0.81%)	4.61 - 16.85	1,589,904	590,000	47,880
Avadel Pharmaceuticals Q2 2023 Earnings Preview [8/8/2023 12:52 PM] Avadel Pharmaceuticals GAAP EPS of -$0.83 misses by $0.45, revenue of $1.5M beats by $0.77M [8/9/2023 7:08 AM]
04-05-2023	AH	After the close (May 4)	AVDL	Avadel Pharmaceuticals	1,034	-0.48	-0.37	0.00	Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10 [5/4/2023 5:19 PM]	14.96	0.71 (5.02%)	14.56	0.31 (2.18%)	1.05 - 15.78	1,985,245	1,540,000	258
Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10 [5/4/2023 5:19 PM]
09-11-2022	PM	7:00 AM ET (Nov 9)	AVDL	Avadel Pharmaceuticals	378.00	-0.33	-0.22	0.00	Avadel Pharmaceuticals GAAP EPS of -$0.33 misses by $0.07 [11/9/2022 7:35 AM]	5.74	-0.48 (-7.69%)	6.36	0.14 (2.25%)	1.05 - 11.59	779,934	450,000	375
Avadel Pharmaceuticals GAAP EPS of -$0.33 misses by $0.07 [11/9/2022 7:35 AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results [Nov-09-22 07:30AM]
09-08-2022	PM	7:00 AM ET (Aug 9)	AVDL	Avadel Pharmaceuticals plc	275.12	-0.50	-0.41	-0.33	Avadel Pharmaceuticals GAAP EPS of -$1.07 misses by $0.66 [8/9/2022 7:02 AM]	7.26	0.95 (15.06%)	6.30	-0.01 (-0.16%)	1.05 - 11.59	1,634,857	670,000	55,951
Avadel Pharmaceuticals Q2 2022 Earnings Preview [8/8/2022 2:33 PM] Avadel Pharmaceuticals GAAP EPS of -$1.07 misses by $0.66 [8/9/2022 7:02 AM]
17-03-2022	PM	8:00 AM ET (Mar 17)	AVDL	Avadel Pharmaceuticals plc	403.89	-0.38	-0.41	-0.24	Avadel Pharmaceuticals GAAP EPS of -$0.38 beats by $0.03 [3/17/2022 7:03 AM]	7.32	0.29 (4.20%)	0.0	0.0 (0.00%)	4.93 - 11.59	940,688	409,773	0
Avadel Pharmaceuticals GAAP EPS of -$0.38 beats by $0.03 [3/17/2022 7:03 AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-17-22 07:00AM]
08-11-2021	PM	8:00 AM ET (Nov 8)	AVDL	Avadel Pharmaceuticals plc	605.89	-0.38	-0.38	-0.20	Avadel Pharmaceuticals EPS beats by $0.01 [11/8/2021 8:13 AM]	10.93	0.51 (4.89%)	10.50	0.08 (0.77%)	5.59 - 11.45	1,263,932	710,000	13,820
Avadel Pharmaceuticals EPS beats by $0.01 [11/8/2021 8:13 AM] Avadel records rising costs in Q3 amid plans to launch narcolepsy therapy [11/8/2021 11:24 AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-08-21 08:00AM] Avadel Pharmaceuticals plc (AVDL) Q3 2021 Earnings Call Transcript [Nov-08-21 03:30PM]
09-08-2021	PM	8:00 AM ET (Aug 9)	AVDL	Avadel Pharmaceuticals plc	454.45	-0.33	-0.31	-0.16	Avadel Pharmaceuticals EPS misses by $0.02 [8/9/2021 8:06 AM]	7.81	-0.09 (-1.14%)	7.89	-0.01 (-0.13%)	4.83 - 10.32	240,276	280,000	151
Avadel Pharmaceuticals EPS misses by $0.02 [8/9/2021 8:06 AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-09-21 08:00AM] Avadel Pharmaceuticals plc (AVDL) Q2 2021 Earnings Call Transcript [Aug-09-21 02:30PM]
10-05-2021	PM	7:00 AM ET (May 10)	AVDL	Avadel Pharmaceuticals plc	433.81	-0.23	-0.32	-0.02	Avadel Pharmaceuticals EPS beats by $0.09 [5/10/2021 8:05 AM]	8.06	-0.11 (-1.35%)	8.34	0.17 (2.08%)	4.83 - 10.32	267,491	260,000	1,609
Avadel Pharmaceuticals EPS beats by $0.09 [5/10/2021 8:05 AM] Avadel Pharmaceuticals Plc to Host Earnings Call [May-10-21 06:45AM] Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-10-21 08:00AM] Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript [May-10-21 06:00PM]
09-03-2021	PM	7:00 AM ET (Mar 9)	AVDL	Avadel Pharmaceuticals plc	449.87	-0.24	-0.28	-0.07	Avadel Pharmaceuticals EPS beats by $0.09 [3/9/2021 7:05 AM]	8.03	0.50 (6.64%)	7.98	0.45 (5.98%)	4.00 - 13.49	342,665	549,622	5,755
Avadel Pharmaceuticals EPS beats by $0.09 [3/9/2021 7:05 AM] Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-09-21 07:00AM] Avadel Pharmaceuticals Plc to Host Earnings Call [Mar-09-21 05:30AM] Avadel Pharmaceuticals plc (AVDL) Q4 2020 Earnings Call Transcript [Mar-09-21 03:00PM]
09-11-2020	PM	8:00 AM ET (Nov 9)	AVDL	Avadel Pharmaceuticals plc	331.28	-0.20	-0.26	-0.24	Avadel Pharmaceuticals EPS beats by $0.04 [11/9/2020 7:04 AM]	6.03	0.63 (11.67%)	5.80	0.40 (7.41%)	4.00 - 13.49	947,065	427,168	26,485

10-08-2020	PM	7:00 AM ET (Aug 10)	AVDL	Avadel Pharmaceuticals plc	492.93	-0.16	-0.18	-0.23	Avadel Pharmaceuticals EPS of $0.49 [8/10/2020 8:02 AM]	7.85	-0.51 (-6.10%)	8.79	0.43 (5.14%)	1.82 - 13.49	536,994	414,418	3,292